Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis
Crossref DOI link: https://doi.org/10.1186/s12885-015-1978-2
Published Online: 2015-12-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Xue-Qin
Li, Chong-Yi
Xu, Ming-Fang
Zhao, Hong
Wang, Dong
Funding for this research was provided by:
National Natural Science Foundation of China (81272599)